- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05813873
The Use of Incentive Spirometry in Adult Patients Hospitalised in a Rehabilitation Center With Long-covid Syndrome
The Use of Incentive Spirometry (Triflow) in Patients With Long Covid
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Randomised controlled trial with 2 groups:Triflow and exercises (intervention) and exercises (control)
Exercises:Exercises in the bed, chair and standing with/without weights, walking, cycle ergometer, treadmill.
Triflow: 10 breaths in and 10 breaths out.
Both groups will have 1 physiotherapy session per day for 6 days per week from admission to discharge.
Sample size:The sample size is 70. We took into consideration the efficacy of completing the recruitment of patients in time. There few published studies with the use of Triflow as their primary intervention with smaller sample sizes.
Population: Adults with long covid hospitalised in the rehabilitation center
Statistical Analysis: will be done through IBM SPSS Statistics 20 and the level of statistical significance will be (p < 0.05).
From the literature and international guidelines, physiotherapy should be offered to people hospitalized with long-COVID, without any serious risks and offering significant benefit.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Larnaca, Cyprus, 7562
- Eden Resort Wellness Rehabilitation Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults who were infected with COVID-19 in the last 6 months and were diagnosed with long-covid syndrome
- Patients must be willing to give written consent for participation in the study
- Negative rapid test for COVID-19
Exclusion Criteria:
- History of diseases that do not allow exercise (e.g. unstable cardiac disease)
- Age < 18 years of age
- Significant cognitive and psychiatric impairments (inability to follow simple commands or give consent)
- Lack of will to do the exercises or refuse to give consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Triflow
Use of Triflow device and exercise regime
|
Triflow
Other Names:
|
|
Active Comparator: Control
Only exercise regime
|
Exercise
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barthel Index
Time Frame: on admission day
|
Measures performance in activities of daily living (eg.stairs, dressing/undressing, washing,eating).
Score from 0 to 100, where 0 indicates total dependence and 100 total independence with activities of daily living.
|
on admission day
|
|
Barthel Index
Time Frame: on discharge day
|
Measures performance in activities of daily living (eg.stairs, dressing/undressing, washing,eating).
Score from 0 to 100, where 0 indicates total dependence and 100 total independence with activities of daily living.
|
on discharge day
|
|
Dyspnoea (Medical Research Council Dyspnoea Scale)
Time Frame: on admission day
|
Assess dyspnoea via MRC dyspnoea scale.
The participants grade their dyspnoea on a scale of 1 to 5. The bigger the number, the worse their dyspnoea is
|
on admission day
|
|
Dyspnoea (Medical Research Council Dyspnoea Scale)
Time Frame: on discharge day
|
Assess dyspnoea via MRC dyspnoea scale.
The participants grade their dyspnoea on a scale of 1 to 5. The bigger the number, the worse their dyspnoea is
|
on discharge day
|
|
Peak Flow Meter
Time Frame: on admission day
|
Assess the respiratory function via peak flow meter.
The participants will take a deep breath and blow the air out into the peak flow meter.
The higher the score the better their respiratory function is
|
on admission day
|
|
Peak Flow Meter
Time Frame: on discharge day
|
Assess the respiratory function via peak flow meter.
The participants will take a deep breath and blow the air out into the peak flow meter.
The higher the score the better their respiratory function is
|
on discharge day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of hospitalisation days
Time Frame: on discharge day
|
Number of days participants stay in the rehabilitation center
|
on discharge day
|
|
Muscle strength (Hand Grip)
Time Frame: on admission day
|
Assess muscle strength for the upper extremities via hand-held dynamometer
|
on admission day
|
|
Muscle strength (Hand Grip)
Time Frame: on discharge day
|
Assess muscle strength for the upper extremities via hand-held dynamometer
|
on discharge day
|
|
Muscle strength and endurance (30 seconds Sit to stand)
Time Frame: on admission day
|
Assess muscle strength for the lower extremities and endurance via 30 seconds sit to stand.
The participants will have to stand up from a chair without using their arms as many times as they can in 30 seconds.
The more times the better their muscle strength and endurance
|
on admission day
|
|
Muscle strength and endurance (30 seconds Sit to stand)
Time Frame: on discharge day
|
Assess muscle strength for the lower extremities and endurance via 30 seconds sit to stand.
The participants will have to stand up from a chair without using their arms as many times as they can in 30 seconds.
The more times the better their muscle strength and endurance
|
on discharge day
|
|
Balance (Berg Balance)
Time Frame: on admission day
|
Assess via Berg Balance Questionnaire, a total of 14 items that asess balance.
from 0 to 56, the higher the score the better balance a person has and has a smaller risk for falls.
|
on admission day
|
|
Balance (Berg Balance)
Time Frame: on discharge day
|
Assess via Berg Balance Questionnaire, a total of 14 items that asess balance.
from 0 to 56, the higher the score the better balance a person has and has a smaller risk for falls.
|
on discharge day
|
|
Cardiorespiratory fitness (Six minutes walking test)
Time Frame: on admission day
|
Assess the cardiorespiratory fitness via 6 minutes walking test.
The participants have to walk for 6 mins independently and the distance they cover is measured.
The bigger the distance the better cardiorespiratory fitness.
|
on admission day
|
|
Cardiorespiratory fitness (Six minutes walking test)
Time Frame: on discharge day
|
Assess the cardiorespiratory fitness via 6 minutes walking test.
The participants have to walk for 6 mins independently and the distance they cover is measured.
The bigger the distance the better cardiorespiratory fitness.
|
on discharge day
|
|
Quality of life (EQ-5D-5L)
Time Frame: on admission day
|
Assess via EQ-5D-5L questionnaire, it has 6 components (movement,self-care, everyday activities, pain/discomfort, stress/depression, and a scale from 0 to 100 for participants to score how they perceive their health on the day( 0 indicates worst heath and 100 best health)
|
on admission day
|
|
Quality of life (EQ-5D-5L)
Time Frame: on discharge day
|
Assess via EQ-5D-5L questionnaire, it has 6 components (movement,self-care, everyday activities, pain/discomfort, stress/depression, and a scale from 0 to 100 for participants to score how they perceive their health on the day( 0 indicates worst heath and 100 best health)
|
on discharge day
|
|
Fatigue (Multidimensional fatigue inventory)
Time Frame: on admission day
|
Assess the feeling of fatigue via Multidimensional fatigue inventory.
it has 20 questions with a scale from 1(yes that is true) to 5 (no that is not true)
|
on admission day
|
|
Fatigue (Multidimensional fatigue inventory)
Time Frame: on discharge day
|
Assess the feeling of fatigue via Multidimensional fatigue inventory.
it has 20 questions with a scale from 1(yes that is true) to 5 (no that is not true)
|
on discharge day
|
|
Timed up and Go
Time Frame: on admission day
|
Assesses mobility and fall risk.
Participants have to walk 3m, the shorter the time the better their mobility
|
on admission day
|
|
Timed up and Go
Time Frame: on discharge day
|
Assesses mobility and fall risk.
Participants have to walk 3m, the shorter the time the better their mobility
|
on discharge day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marina Kloni, European University Cyprus
Publications and helpful links
General Publications
- Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care. 2011 Oct;56(10):1600-4. doi: 10.4187/respcare.01471.
- Basoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD. Respirology. 2005 Jun;10(3):349-53. doi: 10.1111/j.1440-1843.2005.00716.x.
- Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020 Nov 9;66(4):480-494. doi: 10.5606/tftrd.2020.6889. eCollection 2020 Dec.
- Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):489-496. doi: 10.1016/j.dsx.2020.04.038. Epub 2020 Apr 28.
- Eltorai AEM, Szabo AL, Antoci V Jr, Ventetuolo CE, Elias JA, Daniels AH, Hess DR. Clinical Effectiveness of Incentive Spirometry for the Prevention of Postoperative Pulmonary Complications. Respir Care. 2018 Mar;63(3):347-352. doi: 10.4187/respcare.05679. Epub 2017 Dec 26.
- Imamura M, Mirisola AR, Ribeiro FQ, De Pretto LR, Alfieri FM, Delgado VR, Battistella LR. Rehabilitation of patients after COVID-19 recovery: An experience at the Physical and Rehabilitation Medicine Institute and Lucy Montoro Rehabilitation Institute. Clinics (Sao Paulo). 2021 Jun 14;76:e2804. doi: 10.6061/clinics/2021/e2804. eCollection 2021.
- Seyller H, Gottlieb M, Colla J. A breath of fresh air: The role of incentive spirometry in the treatment of COVID-19. Am J Emerg Med. 2021 Oct;48:369. doi: 10.1016/j.ajem.2021.01.084. Epub 2021 Feb 1. No abstract available.
- Spielmanns M, Pekacka-Egli AM, Schoendorf S, Windisch W, Hermann M. Effects of a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients. Int J Environ Res Public Health. 2021 Mar 7;18(5):2695. doi: 10.3390/ijerph18052695.
- Zampogna E, Paneroni M, Belli S, Aliani M, Gandolfo A, Visca D, Bellanti MT, Ambrosino N, Vitacca M. Pulmonary Rehabilitation in Patients Recovering from COVID-19. Respiration. 2021;100(5):416-422. doi: 10.1159/000514387. Epub 2021 Mar 30.
- Toor H, Kashyap S, Yau A, Simoni M, Farr S, Savla P, Kounang R, Miulli DE. Efficacy of Incentive Spirometer in Increasing Maximum Inspiratory Volume in an Out-Patient Setting. Cureus. 2021 Oct 4;13(10):e18483. doi: 10.7759/cureus.18483. eCollection 2021 Oct.
- Franklin E, Anjum F. Incentive Spirometer and Inspiratory Muscle Training. 2023 Apr 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK572114/
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Post-Infectious Disorders
- COVID-19
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Respiratory Tract Infections
- Infections
- RNA Virus Infections
- Virus Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia, Viral
- Pneumonia
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- Post-Acute COVID-19 Syndrome
Other Study ID Numbers
- Triflow
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Long COVID
-
Fundacion Miguel ServetRecruiting
-
Miami VA Healthcare SystemNot yet recruiting
-
National Defense Medical Center, TaiwanCompletedLong COVID SymptomsTaiwan
-
Universidad Rey Juan CarlosNot yet recruitingPost COVID Syndrome | Long Covid | Long COVID Fatigue | Post COVID Syndrome Long Covid
-
Endourage, LLCCompletedLong COVID | Long Covid19 | Post-Acute COVID-19 | Long Haul COVID | Long-Haul COVID-19 | Post-Acute COVID-19 SyndromeUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingLong COVID | Post COVID Syndrome | Long COVID-19 Syndrome | Long COVID SyndromeNetherlands
-
Anxiety Relief CenterCompleted
-
Rutger LalieuDaVinci KliniekActive, not recruitingLong COVID | Long Covid19 | Long COVID-19 Syndrome | Long Covid 19Netherlands
-
University of LouisvilleRecruitingLong-COVID | Long COVID Syndrome | PASCUnited States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
Clinical Trials on Triflow
-
Atlas UniversityRecruitingSurgery | Mitral Valve FailureTurkey
-
Kastamonu UniversityRecruiting